Canada Healthcare Potentially Undervalued Companies

Companies with a Value score of at least 3, ordered by Value score

GlobalUnited StatesAustraliaUnited KingdomCanadaIndiaChinaArgentinaAustriaBahrainBangladeshBelgiumBermudaBotswanaBrazilBulgariaChileColombiaCroatiaCyprusCzech RepublicDenmarkEgyptEstoniaFinlandFranceGermanyGhanaGreeceHong KongHungaryIcelandIndonesiaIrelandIsraelItalyIvory CoastJamaicaJapanJordanKazakhstanKenyaKuwaitLatviaLebanonLithuaniaLuxembourgMalawiMalaysiaMaltaMauritiusMexicoMoroccoNamibiaNetherlandsNew ZealandNigeriaNorwayOmanPakistanPalestinian AuthorityPeruPhilippinesPolandPortugalQatarRomaniaRussiaSaudi ArabiaSerbiaSingaporeSlovakiaSloveniaSouth AfricaSouth KoreaSpainSri LankaSwedenSwitzerlandTaiwanTanzaniaThailandTrinidad & TobagoTunisiaTurkeyUgandaUkraineUnited Arab EmiratesVenezuelaVietnamZambiaZimbabwe

Hamilton Thorne

(HTL)

Hamilton Thorne Ltd., together with its subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets.

Viemed Healthcare

(VMD)

Viemed Healthcare, Inc., through its subsidiaries, provides in-home health care solutions in the United States.

Medical Facilities

(DR)

Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals and an ambulatory surgery center in the United States.

Manitex Capital

(MNX)

Manitex Capital Inc., through its subsidiary, Valeo Pharma Inc., acquires and markets specialty pharmaceutical products, and distributes third-party pharmaceutical products primarily in Canada.

Akumin

(AKU)

Akumin Inc. provides outpatient diagnostic imaging services in the United States.

HLS Therapeutics

(HLS)

HLS Therapeutics Inc., a specialty pharmaceutical company, focuses on acquiring and commercializing pharmaceutical products in the specialty central nervous system and cardiovascular markets.